Daily Morning Note – 5 Nov 2019



Asian stocks are poised to consolidate gains Tuesday after another strong session on Wall Street as the U.S. and China inch closer to a trade deal. Treasuries tumbled.

Futures signaled equities will open firmer in Japan, with Hong Kong shares set to slip after the biggest jump in three weeks Monday.

Australian stocks opened slightly higher. U.S. futures were flat. The Dow Jones Industrial Average claimed its first all-time high since July, and the S&P 500 and Nasdaq indexes also hit new highs.

China is reviewing locations in the U.S. where President Xi Jinping would be willing to meet with President Donald Trump to sign the first phase of a trade deal between the world’s two-largest economies, people familiar with the plans said. The 10-year Treasury yield rose to 1.78% and the dollar advanced versus major peers.


Oil prices rose on Monday, buoyed by an improved outlook for crude demand as better-than-expected US jobs growth added to market hopes a preliminary US-China trade deal would be reached this month.

Global stock markets rallied on Monday, with major US indices surging to fresh records on optimism over international trade talks and continued positive momentum from solid economic data and earnings.

SINGAPORE’S second-largest bank OCBC Bank is understood to be in firm talks with Keppel Corporation, peer-to-peer lender Validus Capital, and Vertex Ventures, to form a digital-bank consortium.

QUETZAL Capital has announced a voluntary conditional cash offer for Pacc Offshore Services Holdings (POSH) at S$0.215 per share in cash.

CHINA Everbright Water on Monday said it has secured Ji’nan Tangye New Area Waste Water Treatment PPP project and Zibo Northern Waste Water Treatment Plant Expansion Project in Shandong province, with a total investment of about 396 million yuan (S$76.3 million).

CHALLENGER Technologies on Monday posted a 5 per cent drop in its third-quarter net profit to S$4.3 million, on the back of flat revenue of S$83.3 million, which rose just 1 per cent from a year ago.

FOOD court and coffeeshop operator Koufu on Monday posted a 52.3 per cent increase in net earnings to S$7.1 million in its third quarter, on the back of a 6.6 per cent rise in revenue to S$61.4 million.

SINGAPORE Press Holdings (SPH) has launched a perpetual issue on Monday, its second such deal this year.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR


China Petroleum & Chemical Corp

Recommended Action: Technical BUY

China petroleum & Chemical (HK: 386) will most likely heading for a bulls recovery based on the technicals

Read more technical reports


Singapore Banking Monthly – Tepid but stable loans growth

Recommendation: Overweight (Maintained)

Analyst: Tin Min Ying

– Singapore’s loans growth for September was tepid but stable at 2.1% YoY.

– Consumer loans contracted for the sixth consecutive month (-1.2% YoY), dragged by weakness in housing loans (-1.3% YoY).

– 3M SIBOR down 7bps to 1.806%, while 3M SOR plunged 17bps to 1.515%.

– CASA growth recovered to 0.9% YoY after almost a year of contraction; while FD kept up its strong momentum at 20.3% YoY.

– In 1Q20 (Jul – Sep), DDAV grew 12% YoY and SDAV growth recovered to -1% YoY as compared to quarterly average contraction of -16% YoY in FY19.

– Maintain the Singapore Banking Sector at Overweight. The banks are offering dividend yield of 4.6% to 5.0%, well capitalised and enjoying 5-9% earnings growth.

NetLink NBN Trust – Organic growth from here

Recommendation: ACCUMULATE (Maintained), Last Done: S$0.945

Target Price: S$0.990, Analyst: Alvin Chia

– Results were within expectations, residential fibre connections rose 13.7 YoY

– NBAP and segment connections increased by 4.3% and 9.4% QoQ respectively

– NLT is supporting M1 and TPG Telecom on their 5G trials in Marina Square and Singapore Science Park I and II

– Maintained ACCUMULATE with a higher TP of S$0.99. We adjusted our WACC downwards to 5.9% to reflect the lower interest rate environment.

Raffles Medical Group Ltd – China remains an earnings drag

Recommendation: NEUTRAL (Maintained), Last Done price: S$1.00

Target Price: S$1.05 (prev TP: S$1.09), Analyst: Tin Min Ying

– 3Q19’s Revenue and PATMI were in line with our estimates.

– 3Q19’s PATMI plunged 16.9% YoY due to gestation costs from Raffles Hospital Chongqing. Excluding China, net earnings would have risen by 4.8% YoY.

– RafflesHospital Chongqing’s 3Q EBITDA loss of $2.6mn was within expectations.

– We keep our NEUTRAL recommendation with a lower TP of S$1.05 (previous TP S$1.09). Earnings will be under pressure from the gestations costs for RafflesHospital Chongqing in 2019 and RafflesHospital Shanghai in 2020.

Micro-Mechanics (Holdings) Ltd – Low volumes, no operating leverage

Recommendation: REDUCE (Downgraded), Last Done: S$1.85

Target Price: S$1.60, Analyst: Paul Chew

– 1Q20 revenue and PATMI were behind our expectations. Lack of revenue growth hurt earnings despite a 4% YoY decline in operating expenses.

– A positive was the QoQ improvement in revenue and margins.

– No change to our FY20e earnings despite the results below expectations. We are still expecting a recovery in 2H20. Semiconductor indicators point to a tentative recovery in volumes. We maintain our target price at S$1.60. Following the recent rally in share price, we are downgrading our recommendation to REDUCE.

Read more research reports

Webinar Of The Week

Market Outlook: : (PSR) Hyphens Pharma, Uunited Overseas Bank Limited (UOB), CapitaLand Mall Trust, Frasers Centrepoint Trust, Sheing Siong Group, Phillip SG Weekly, US Weekly, US Banking & Technical Analysis

Date: 04 November 2019

For more on Market Outlook

Phillip Research in 3 minutes: #16- JEP Holdings Ltd

Updates summarised in 3 minutes

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com